LBA16 Dalpiciclib plus letrozole or anastrozole as first-line treatment for HR+/HER2- advanced breast cancer (DAWNA-2): A phase III trial
Binghe Xu, Qilong Zhang, Ping Zhang, Zhong Sheng Tong, Tao Sun, W. Li, Quchang Ouyang, Xin Hu, Y. Cheng, Min Yan, Yuee Teng, Yacheng Pan, Xiaoyu Yan, Yue Wang, Wenqiang Xie, Xiaohua Zeng, Shuping Jiang, Nayima Bayaxi, Xinyu Zhu
Topics & Concepts
AnastrozoleMedicineLetrozoleFulvestrantInternal medicineClinical endpointBreast cancerPlaceboNeutropeniaMetastatic breast cancerOncologyInterim analysisPhases of clinical researchProgression-free survivalRandomized controlled trialCancerTamoxifenClinical trialChemotherapyAlternative medicinePathologyAdvanced Breast Cancer TherapiesCancer Treatment and PharmacologyHER2/EGFR in Cancer Research